Co-Diagnostics, Inc. Deferred Federal Income Tax Expense (Benefit)
Co-Diagnostics, Inc. (CODX) reported Deferred Federal Income Tax Expense (Benefit) of -$7.84 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-31
- Co-Diagnostics, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$7.84M.
- Co-Diagnostics, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$7.61M.
- Co-Diagnostics, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$7.23M.
- Co-Diagnostics, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$3.95M, a 382.87% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$7.84M 10-K · filed 2026-03-31 |
| 2024-12-31 | -$7.61M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$7.23M 10-K · filed 2025-03-27 |
| 2022-12-31 | -$3.95M 10-K · filed 2024-03-14 |
| 2021-12-31 | $1.39M 10-K · filed 2023-03-16 |
| 2020-12-31 | -$452.54K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |